A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Public Consultation |
---|---|
Submitter | France |
Regulatory programme |
|
CLP Annex VI Index Number |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Hazard classes open for commenting | Acute toxicity Respiratory sensitization Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — repeated exposure |
Proposed specific concentration limits by the dossier submitter | ATE oral = 100 mg/kg ATE inhal = 0.005 mg/L |
Intention timeline
Date of intention | 2018-02-23 |
---|---|
Expected date of submission | 2019-02-28 |
Submitted for accordance check | 2019-03-15 |
Final submission date | 2019-08-07 |
Start of consultation | 2019-09-23 |
Deadline for commenting | 2019-11-22 |
Legal deadline for opinion adoption | 2021-02-05 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Dec. 9, 2019
- Status: Public Consultation → Opinion Development
Dec. 17, 2019
- Comments received: https://echa.europa.eu/documents/10162/e0c5ee60-c5d1-0f8c-b62e-d6683b7c7c18
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/b7879a3a-679c-9c85-ab3f-309696f3c304
July 28, 2020
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/12712fb8-3a23-c5fd-d352-4db9527f79f3 → https://echa.europa.eu/documents/10162/0aef48bf-df29-5a5c-849c-2e37d18e92ac
- CLH report: https://echa.europa.eu/documents/10162/0514d7b0-6ff6-1d6b-b91d-098e97392c9b → https://echa.europa.eu/documents/10162/fb84f820-c0f8-5ece-396b-956907d154ab
- Comments received: https://echa.europa.eu/documents/10162/e0c5ee60-c5d1-0f8c-b62e-d6683b7c7c18 → https://echa.europa.eu/documents/10162/76b40e2c-13f5-0e4e-415b-4a606642b351
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/b7879a3a-679c-9c85-ab3f-309696f3c304 → https://echa.europa.eu/documents/10162/c287d4da-956a-b941-5ca7-a26c313f461c
Sept. 30, 2020
- Date of opinion: 2020-09-17
Jan. 19, 2021
- Status: Opinion Development → Opinion Adopted
Feb. 16, 2021
- Comments received: https://echa.europa.eu/documents/10162/76b40e2c-13f5-0e4e-415b-4a606642b351
Feb. 17, 2021
- Background document: https://echa.europa.eu/documents/10162/9f5209f4-0305-a830-9898-91754029b439
- Comments received: https://echa.europa.eu/documents/10162/85072b3d-92c2-5fe2-e79a-13545ec6a33d
- Date of opinion: 2020-09-17 → 2020-12-10
- Minority opinions: https://echa.europa.eu/documents/10162/eb372676-cd03-fb54-7c49-de0a0f45f334
- RAC opinion: https://echa.europa.eu/documents/10162/888d4c0b-82be-a527-2e06-52db6ac44607
March 27, 2021
- Name: Divanadium pentaoxide → divanadium pentaoxide;vanadium pentoxide
April 9, 2021
- Name: divanadium pentaoxide;vanadium pentoxide → Divanadium pentaoxide
June 1, 2021
- RAC opinion: https://echa.europa.eu/documents/10162/888d4c0b-82be-a527-2e06-52db6ac44607 → https://echa.europa.eu/documents/10162/6c9565dd-6350-5498-4d9d-b239ddbc88c8
Jan. 18, 2023
- ATP number and date: ATP18 - (16/02/2022), 23/11/2023
- Link to ATP / File Title: Official Journal
- Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
This version
Sept. 24, 2019
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/12712fb8-3a23-c5fd-d352-4db9527f79f3
- CLH report: https://echa.europa.eu/documents/10162/0514d7b0-6ff6-1d6b-b91d-098e97392c9b
- Deadline for commenting: 2019-11-22
- Final submission date: 2019-08-07
- Hazard classes open for commenting: Acute toxicity Respiratory sensitization Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — repeated exposure
- Legal deadline for opinion adoption: 2021-02-05
- Status: Submitted → Public Consultation
- Start of consultation: 2019-09-23
April 4, 2019
- Regulatory programme: Other substance → Chemical registered under REACH
March 20, 2019
- Harmonised classification at the time of the proposal: Repr. 2, H361d → Repr. 2, H361d***
- Harmonised classification at the time of the proposal: STOT RE 1, H372 → STOT RE 1, H372**
- Proposed harmonised classification by the dossier submitter: Acute Tox. 4, H302 → Acute Tox. 1, H330
- Proposed harmonised classification by the dossier submitter: Acute Tox. 4, H332 → Acute Tox. 3, H301
- Proposed harmonised classification by the dossier submitter: Muta. 2, H341 → Muta. 1B, H340
- Proposed harmonised classification by the dossier submitter: Repr. 2, H361fd → Repr. 1B, H360Fd
- Proposed harmonised classification by the dossier submitter: STOT RE 1, H372
- Proposed specific concentration limits by the dossier submitter: ATE oral = 100 mg/kg ATE inhal = 0.005 mg/L
- Status: Intention → Submitted
- Submitted for accordance check: 2019-03-15
Dec. 20, 2018
- Expected date of submission: 2018-10-31 → 2019-02-28
Add the related substance to your watchlist to monitor this regulatory record.